Back
Black Diamond Therapeutics Stock Price Chart
Try a Free Stock Analysis With Definitive Buy Sell Hold Ratings
Analyze Any Stock Free
Sell
40
BDTX
Black Diamond Therapeutics
Last Price:
$2.25
Seasonality Move:
1.4%
7 Day Trial
ALL ACCESS PASS
$
7
Free Stock Analysis Report: Get a clear concise Stock Rating
Analyze Any Stock Free-
The current trend is relatively stagnant and BDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Black Diamond Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.14 | Buy |
| 20-day SMA: | 2.24 | Buy |
| 50-day SMA: | 2.53 | Sell |
| 200-day SMA: | 4.47 | Sell |
| 8-day EMA: | 2.17 | Buy |
| 20-day EMA: | 2.24 | Buy |
| 50-day EMA: | 2.61 | Sell |
| 200-day EMA: | 3.73 | Sell |
Black Diamond Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 47.5 | Sell |
| Chaikin Money Flow: | 1402601 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.11 - 2.45) | Sell |
| Bollinger Bands (100): | (2.2 - 4.94) | Sell |
Black Diamond Therapeutics Technical Analysis
| Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Black Diamond Therapeutics Stock
Is Black Diamond Therapeutics Stock a Buy?
-
Black Diamond Therapeutics share price is 2.25 while BDTX 8-day simple moving average is 2.14, which is a Buy signal.
-
The stock price of BDTX is 2.25 while Black Diamond Therapeutics 20-day SMA is 2.24, which makes it a Buy.
-
Black Diamond Therapeutics 50-day simple moving average is 2.53 while BDTX share price is 2.25, making it a Sell technically.
-
BDTX stock price is 2.25 and Black Diamond Therapeutics 200-day simple moving average is 4.47, creating a Sell signal.
BDTX Technical Analysis vs Fundamental Analysis
Sell
40
Black Diamond Therapeutics (BDTX)
is a Sell
Is Black Diamond Therapeutics a Buy or a Sell?
-
Black Diamond Therapeutics stock is rated a SellThe current Black Diamond Therapeutics [BDTX] share price is $2.25. The Score for BDTX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Black Diamond Therapeutics Stock Info
Market Cap:
127.3M
Price in USD:
2.25
Share Volume:
1.9M
Black Diamond Therapeutics 52-Week Range
52-Week High:
7.66
52-Week Low:
1.91
Sell
40
Black Diamond Therapeutics (BDTX)
is a Sell
Black Diamond Therapeutics Share Price Forecast
-
What is the Black Diamond Therapeutics stock price today?The Black Diamond Therapeutics stock price is 2.25 USD today.
-
Will BDTX stock go up or go down?Black Diamond Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Black Diamond Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Black Diamond Therapeutics is overvalued.
Is Black Diamond Therapeutics Stock a Buy?
-
Black Diamond Therapeutics share price is 2.25 while BDTX 8-day exponential moving average is 2.17, which is a Buy signal.
-
The stock price of BDTX is 2.25 while Black Diamond Therapeutics 20-day EMA is 2.24, which makes it a Buy.
-
Black Diamond Therapeutics 50-day exponential moving average is 2.61 while BDTX share price is 2.25, making it a Sell technically.
-
BDTX stock price is 2.25 and Black Diamond Therapeutics 200-day simple moving average is 3.73, creating a Sell signal.
Fundamental Analysis of Black Diamond Therapeutics
Is Black Diamond Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.18 per share.
Technical Analysis of Black Diamond Therapeutics
Should I short Black Diamond Therapeutics stock?
-
BDTX Moving Average Covergence Divergence (MACD) indicator is -0.12, suggesting Black Diamond Therapeutics is a Sell
-
Black Diamond Therapeutics Relative Strength Index (RSI) is 47.5, which suggest Black Diamond Therapeutics is oversold
-
The Bollinger Bands (25) for Black Diamond Therapeutics is (2.11 - 2.45), which suggest Black Diamond Therapeutics is a Sell
-
The Bollinger Bands (100) for Black Diamond Therapeutics is (2.2 - 4.94), which suggest Black Diamond Therapeutics is a Sell
* Black Diamond Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.